← Open Payments lookup

STEPHANIE DOUGLASS: Open Payments

NPI 1386904803 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$481 in 27 payments from 10 companies in 2025. Trend: 2023 $434 · 2024 $177 · 2025 $481

Food & beverage: $481
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.8$144
ABBVIE INC.3$65
Vanda Pharmaceuticals Inc.3$46
Otsuka America Pharmaceutical, Inc.2$42
Alkermes, Inc.2$42
Corium, LLC2$35
Janssen Pharmaceuticals, Inc2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$30
Collegium Pharmaceutical, Inc.2$28
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: Qelbree, VRAYLAR, FANAPT, ARISTADA, Azstarys, INVEGA SUSTENNA, CAPLYTA, Jornay PM.

Industry payments across MS — which companies pay providers there.